NCT07165106Completed
Effects of Resistance and Aerobic Exercises on Walking and Sarcopenic Parameters in Parkinson's Disease
Comparison of the Effects of Resistance and Aerobic Exercises Added to Conventional Rehabilitation Program on Walking and Sarcopenic Parameters in Patients With Sarcopenic Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 2 Apr 2026
Brief summary (registry, in English)
The aim of this study was to investigate the effects of resistance and aerobic exercises on the following outcomes in patients with sarcopenic Parkinson's disease: Timed Up and Go Test (TUG), gait speed, Short Physical Performance Battery (SPPB), handgrip strength, Five-Times Sit-to-Stand Test, and MDS-UPDRS Part II scores.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 25 Aug 2025
- Start date
- 10 Sept 2025
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- Ahi Evran University Education and Research Hospital
- Diseases
- Parkinson disease
- NCT number
- NCT07165106
What you commit to
- Study type: Interventional
- Participants enrolled: 32
- From 10 Sept 2025 to the primary completion date, 1 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Failure to meet diagnostic criteria for sarcopenia.
- History of malignancy.
- Epilepsy.
- History of cardiac pacemaker implantation.
- Presence of congestive heart failure.
- Orthopedic conditions affecting walking or balance.
- Respiratory disorders impairing exercise capacity.
- Uncontrolled hypertension.
- History of neuromuscular or vestibular disorders affecting gait or balance parameters.
Other
- Hoehn \& Yahr stage 1 or 4.
- Inability to cooperate with study procedures.
- Lack of willingness to participate in the study.
Who the study is looking for
- Male and female patients aged 40-85 years with a clinical diagnosis of Parkinson's disease.
- Diagnosis of sarcopenia according to the EWGSOP2 criteria.
- Hoehn \& Yahr stage 2-3.
- Ability and willingness to provide written informed consent according to the approved study consent form.
Age in the registry: 40 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kırşehir Ahi Evran University Coordinator of this site? Confirm its status | Kırşehir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.